1.Optimization of Stent Deployment by Intravascular Ultrasound.
The Korean Journal of Internal Medicine 2012;27(1):30-38
Intravascular ultrasound (IVUS) is a useful diagnostic method that provides valuable information in addition to angiography regarding the coronary vessel lumen, dimensions, plaque burden, and characteristics. The major use of IVUS in coronary intervention is to guide interventional strategies and assess optimal stent deployment. Since the introduction of the drug-eluting stent (DES), concerns about restenosis have decreased. However, high-risk lesion subsets are being routinely treated with DESs, and the incidence of suboptimal results after stent deployment, such as stent underexpansion, incomplete stent apposition, edge dissection, geographic miss, and the risk of stent thrombosis, have correspondingly increased. Thus, optimization of stent deployment under IVUS guidance may be clinically important. In this review, we focus on the potential role of IVUS in stent optimization during percutaneous coronary intervention and its clinical benefits.
Angioplasty, Balloon, Coronary/adverse effects/*instrumentation/mortality
;
Coronary Artery Disease/mortality/*therapy/*ultrasonography
;
Coronary Restenosis/etiology
;
Drug-Eluting Stents
;
Evidence-Based Medicine
;
Humans
;
Myocardial Infarction/etiology
;
Prosthesis Design
;
*Stents
;
Thrombosis/etiology
;
Treatment Outcome
;
*Ultrasonography, Interventional
2.Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents.
Jang Won SON ; Ung KIM ; Jong Seon PARK ; Young Jo KIM ; Jae Sik JANG ; Tae Hyun YANG ; Dong Soo KIM ; Dong Kie KIM ; Sang Hoon SEOL ; Doo Il KIM ; Chang Wook NAM ; Seung Ho HUR ; Kwon Bae KIM
The Korean Journal of Internal Medicine 2013;28(1):72-80
BACKGROUND/AIMS: The Taxus Liberte stent (Boston Scientific Co.) evolved from the Taxus Express stent, with enhanced stent deliverability and uniform drug delivery. This study was designed to compare angiographic and clinical outcomes in real-world practice between the Taxus Liberte and Taxus Express stents. METHODS: Between 2006 and 2008, 240 patients receiving the Taxus Liberte stent at three centers were registered and compared to historical control patients who had received the Taxus Express stent (n = 272). After propensity score matching, 173 patients treated with the Taxus Liberte stent and the same number of patients treated with the Taxus Express stent were selected. The primary outcome was a composite of major adverse cardiac events (MACE), including cardiac death, myocardial infarction (MI), ischemia driven target vessel revascularization (TVR), and stent thrombosis (ST) at 1 year. An additional angiographic assessment was conducted at 9 to 12 months. RESULTS: The study showed no significant difference between the Taxus Express and Taxus Liberte stents (death, 1.73% vs. 2.31%, p = 1.000; MI, 0% vs. 1.73%, p = 0.2478; TVR, 2.31% vs. 1.16%, p = 0.6848; and ST, 0% vs. 1.16%, p = 0.4986). The total MACE rate at 1 year did not differ between the groups (4.05% in Taxus Express vs. 4.05% in Taxus Liberte, p = 1.000). In addition, the binary restenosis rate did not differ (2.25% in Taxus Express vs. 1.80% in Taxus Liberte, p = 0.6848). CONCLUSIONS: In real-world experience with the two Taxus stent designs, both stents showed similarly good clinical and angiographic outcomes at 1 year. A long-term follow-up study is warranted.
Aged
;
Angioplasty, Balloon, Coronary/adverse effects/*instrumentation/mortality
;
Cardiovascular Agents/administration & dosage
;
Chi-Square Distribution
;
Coronary Angiography
;
Coronary Artery Disease/mortality/radiography/*therapy
;
Coronary Restenosis/etiology/mortality
;
Coronary Thrombosis/etiology/mortality
;
*Drug-Eluting Stents
;
Female
;
Humans
;
Male
;
Middle Aged
;
Myocardial Infarction/etiology/mortality
;
Paclitaxel/*administration & dosage
;
Propensity Score
;
Prosthesis Design
;
Registries
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Stainless Steel
;
Time Factors
;
Treatment Outcome